Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Fidelity Select Sector funds -- Ignore unavailable to you. Want to Upgrade?

To: seminole who wrote (2881)	9/4/2000 11:38:34 AM
From: Julius Wong	Read Replies (2) \| Respond to of 4916

From Barrons, September 4, 2000 ... ... ... ... Frankly, xenotransplantation was Greek to us until we came across it in our favorite medical journal, The Wall Street Journal. Not only did we learn what it meant -- transplanting organs from one species to another -- but also that the process of using animals as organ donors for humans, which had defied every effort by brave biotechnicians to put it into practice, suddenly looks doable! In no small measure, the Journal informed us, we can direct our hurrahs toward a small company fittingly called BioTransplant, which has bred a line of miniature pigs that happily do not send harmful pig viruses along with any of their organs when implanted in Homosapiens. The obvious market is folks in need of new kidneys, livers and hearts. But given the miraculous powers of modern science, we envision brain transplants -- and of brain slivers -- as well. And it's here that we foresee a huge, revolutionary impact on Wall Street. For its denizens seem especially amenable to xenotransplantation, since pigs have long been as prominent a part of the investment landscape as bulls and bears, as evidenced by the old stock market ditty that "bulls make money, bears make money but pigs make more money than anyone." Just think of the impact of a modicum of gray matter transferred from those miniature pigs to the multitude of timid investors. We're talking especially about the twitchy souls who squirrel away their dough in money market funds. At last count, there was a tidy $1.75 trillion in those still-water repositories, of which nearly $1 trillion represents individual (as against institutional) money. Infuse these timorous masses with the right quotient of hoggishness -- or greed, as it is called in human parlance -- and they and their trillion bucks will fling themselves at the stock market. Result: Dow 36,000 by Christmas, guaranteed! And imagine what a tiny slice of frontal lobe from a cute little pig could do for analysts. Instead of that cautious reckoning that the stock they're touting is slated to rise from its current price of 25 to 200, they can hyperventilate in earnest and boldly predict said stock is sure to hit 400 on its way to 600. Scores -- we're too conservative -- hundreds of stocks will rocket skyward. There's always a danger, to be sure, that the powers of those miniature pigs will diminish because of overbreeding, and the potency of the transplants will decline accordingly. However, in the event, lucky Wall Street has a ready means of reinvigorating or even upgrading the line of midget swine. Xenotransplantation, after all, works both ways. Just a speck from the cranial region of an investment banker implanted in a pig's brain would mightily enhance the vital element of hoggishness. Seems only fair, in any case, that those little porkers should get something in return. Get ready with joy in your heart and money in your hand to welcome the Age of Xenotransplantation. So far as we're concerned, pig heaven just can't come soon enough. ... ... ... ...